Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature
M Nasser, TR Larsen, B Waanbah, I Sidiqi… - Drug, healthcare and …, 2013 - Taylor & Francis
Amiodarone is a benzofuran class III antiarrhythmic drug used to treat a wide spectrum of
ventricular tachyarrhythmias. The parenteral formulation is prepared in polysorbate 80 …
ventricular tachyarrhythmias. The parenteral formulation is prepared in polysorbate 80 …
Amiodarone-induced acute hepatotoxicity
U Rao, A Agarwal - European journal of clinical pharmacology, 2012 - Springer
Discussion Amiodarone is a commonly used antiarrhythmic. It is associated with
extracardiac side effects, including asymptomatic hepatic dysfunction in 15–40% of patients …
extracardiac side effects, including asymptomatic hepatic dysfunction in 15–40% of patients …
Acute liver and renal failure: a rare adverse effect exclusive to intravenous form of amiodarone
R Paudel, P Dogra, S Suman… - Case Reports in …, 2016 - Wiley Online Library
Amiodarone is an antiarrhythmic drug which is highly effective against a wide spectrum of
ventricular tachyarrhythmias making it irreplaceable in certain group of patients. We report …
ventricular tachyarrhythmias making it irreplaceable in certain group of patients. We report …
Early-onset acute toxic hepatitis induced by intravenous amiodarone administration
G Sánchez, M la Mata García - Gastroenterología y hepatología, 2002 - europepmc.org
Amiodarone is a widely used and effective long-term antiarrhythmic drug but with known
adverse effects. Prolonged oral administration of this drug has been implicated in numerous …
adverse effects. Prolonged oral administration of this drug has been implicated in numerous …
[PDF][PDF] Fatal acute liver failure after intravenous amiodarone administration
JG Li, TC Yang, DM Yu, TH Ren - J Formos Med Assoc, 2015 - core.ac.uk
Acute hepatotoxicity is a rare adverse effect of intravenous administration of amiodarone, but
may be fatal if not recognized early and treated in a timely manner. Herein we report two …
may be fatal if not recognized early and treated in a timely manner. Herein we report two …
Acute hepatotoxicity of intravenous amiodarone: case report and review of the literature
CC Chen, CC Wu - American journal of therapeutics, 2016 - journals.lww.com
Amiodarone is a class III antiarrhythmic drug widely used for the treatment of both
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …
Acute hepatic failure following intravenous amiodarone
R Grecian, M Ainslie - Case Reports, 2012 - casereports.bmj.com
A 73-year-old gentleman presented to the hospital after an episode of loss of
consciousness. He had a defibrillator in situ, which on interrogation was found to have fired …
consciousness. He had a defibrillator in situ, which on interrogation was found to have fired …
[HTML][HTML] Hepatic dysfunction in patients receiving intravenous amiodarone
A Hashmi, NR Keswani, S Kim… - Southern medical …, 2016 - ncbi.nlm.nih.gov
Objectives Amiodarone is a commonly used anti-arrhythmic drug. Hepatotoxicity following
chronic oral administration occurs in 1% to 3% of patients. Hepatotoxicity following …
chronic oral administration occurs in 1% to 3% of patients. Hepatotoxicity following …
Acute liver failure with amiodarone infusion: A case report and systematic review
What is known and objective Amiodarone, a commonly used class III antiarrhythmic agent
notable for a relatively long half‐life of up to 6 months and its pronounced adverse effect …
notable for a relatively long half‐life of up to 6 months and its pronounced adverse effect …
[HTML][HTML] Acute hepatitis after amiodarone infusion
P Fonseca, A Dias, H Gonçalves… - World Journal of …, 2015 - ncbi.nlm.nih.gov
Acute hepatitis is a very rare, but potentially fatal, adverse effect of intravenous amiodarone.
We present a case of an 88-year-old man with history of ischemic dilated cardiomyopathy …
We present a case of an 88-year-old man with history of ischemic dilated cardiomyopathy …